CAS: 2140301-98-8
Fórmula:C25H36F3N5O3·C4H6O4
InChI:InChI=1S/C25H36F3N5O3.C4H6O4/c1-15(2)24(6-4-16(10-24)31-19-5-7-36-13-20(19)35-3)23(34)33-12-17-8-18(33)11-32(17)22-9-21(25(26,27)28)29-14-30-22;5-3(6)1-2-4(7)8/h9,14-20,31H,4-8,10-13H2,1-3H3;1-2H2,(H,5,6)(H,7,8)/t16-,17+,18+,19+,20-,24+;/m1./s1
Clave InChI:InChIKey=WRPPUEHVLSHXJG-HTQYHTRRSA-N
SMILES:O=C(O)CCC(=O)O.O=C(N1CC2N(C3=NC=NC(=C3)C(F)(F)F)CC1C2)C4(CCC(NC5CCOCC5OC)C4)C(C)C
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Pf-04634817 succinate REF: 3D-QKD30198CAS: 2140301-98-8 | Min. 95% | A consultar | Mar 11 Feb 25 |
 | PF-04634817 succinate REF: TM-T12419CAS: 2140301-98-8 | 98% | 1.095,00 €~2.899,00 € | Mar 04 Mar 25 |
Pf-04634817 succinate
CAS:2140301-98-8
Please enquire for more information about Pf-04634817 succinate including the price, delivery time and more …
Fórmula:
C29H42F3N5O7
Pureza:
Min. 95%
Peso molecular:
629.7 g/mol
Ref: 3D-QKD30198
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 11 de Febrero de 2025
PF-04634817 succinate
CAS:2140301-98-8
PF-0463481 succinate is a potent and orally active dual antagonist of CCR2/CCR5 with comparable human …
Fórmula:
C29H42F3N5O7
Pureza:
98%
Forma y color:
Solid
Peso molecular:
629.67
Ref: TM-T12419
| 25mg | 1.688,00 € | ||
| 50mg | 2.226,00 € | ||
| 100mg | 2.899,00 € |
Entrega estimada en Estados Unidos, el Martes 4 de Marzo de 2025
